• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性肌炎/皮肌炎患者的可溶性CD4、CD8

Soluble CD4, CD8 in patients with polymyositis/dermatomyositis.

作者信息

Tokano Y, Obara T, Hashimoto H, Okumura K, Hirose S

机构信息

Department of Internal Medicine, Juntendo University, School of Medicine, Tokyo, Japan.

出版信息

Clin Rheumatol. 1993 Sep;12(3):368-74. doi: 10.1007/BF02231582.

DOI:10.1007/BF02231582
PMID:8258239
Abstract

The concentrations of soluble CD4 (sCD4) and soluble CD8 (sCD8) were determined in 64 patients with polymyositis/dermatomyositis (PM/MD). The patients with PM/DM had significantly higher concentrations of sCD8, though the concentrations of sCD4 did not significantly increase. Patients with high concentrations of sCD8 tended to have too high concentrations of soluble interleukin-2 receptor (sIL-2R). The patients with high levels of myogenic enzymes tended to have high concentrations of sCD8. The results of a serial study indicated that the concentrations of sCD8 decreased simultaneously with the decrease of the myogenic enzymes. These results may suggest that the activation of CD8+ cells are related to muscular involvement.

摘要

测定了64例多发性肌炎/皮肌炎(PM/DM)患者可溶性CD4(sCD4)和可溶性CD8(sCD8)的浓度。PM/DM患者的sCD8浓度显著更高,尽管sCD4浓度没有显著升高。sCD8浓度高的患者往往可溶性白细胞介素-2受体(sIL-2R)浓度也过高。肌源性酶水平高的患者往往sCD8浓度也高。一项系列研究结果表明,sCD8浓度随着肌源性酶的降低而同时下降。这些结果可能提示CD8+细胞的激活与肌肉受累有关。

相似文献

1
Soluble CD4, CD8 in patients with polymyositis/dermatomyositis.多发性肌炎/皮肌炎患者的可溶性CD4、CD8
Clin Rheumatol. 1993 Sep;12(3):368-74. doi: 10.1007/BF02231582.
2
Changes in levels of soluble T-cell activation markers, sIL-2R, sCD4 and sCD8, in relation to disease exacerbations in patients with systemic lupus erythematosus: a prospective study.系统性红斑狼疮患者可溶性T细胞活化标志物、可溶性白细胞介素-2受体、可溶性CD4和可溶性CD8水平变化与疾病加重的关系:一项前瞻性研究
Ann Rheum Dis. 1994 Apr;53(4):235-9. doi: 10.1136/ard.53.4.235.
3
Soluble CD4 and CD8 in the peripheral blood of patients with multiple sclerosis and HTLV-1-associated myelopathy.
J Neuroimmunol. 1991 Dec;35(1-3):285-93. doi: 10.1016/0165-5728(91)90182-7.
4
Increased levels of soluble CD8 and CD4 in patients with infectious mononucleosis.
Br J Haematol. 1995 Jan;89(1):47-54. doi: 10.1111/j.1365-2141.1995.tb08912.x.
5
Behavior of serum soluble interleukin-2 receptor, soluble CD8 and soluble CD4 in the early phases of acute pancreatitis.急性胰腺炎早期血清可溶性白细胞介素-2受体、可溶性CD8和可溶性CD4的变化
Digestion. 1994;55(4):268-73. doi: 10.1159/000201159.
6
Soluble interleukin 2 receptor and soluble CD8 levels in previously treated human immunodeficiency virus-negative hemophiliacs multiply transfused with a monoclonal antibody-purified factor VIII concentrate.曾接受治疗的人类免疫缺陷病毒阴性血友病患者多次输注单克隆抗体纯化的凝血因子VIII浓缩物后的可溶性白细胞介素2受体和可溶性CD8水平
Transfusion. 1997 Jan;37(1):86-9. doi: 10.1046/j.1537-2995.1997.37197176956.x.
7
Soluble interleukin-2 receptor, CD4 and CD8 levels in melanoma: a longitudinal study.黑色素瘤中可溶性白细胞介素-2受体、CD4和CD8水平:一项纵向研究。
Dermatology. 1992;184(3):182-9. doi: 10.1159/000247537.
8
Soluble CD4 and CD8 in serum from patients with localized scleroderma.局限性硬皮病患者血清中的可溶性CD4和CD8
Arch Dermatol Res. 1996 Jun;288(7):358-62. doi: 10.1007/BF02507103.
9
Changes in soluble CD4 and CD8 proteins in healthy pregnant and postpartum women.健康孕妇和产后妇女可溶性CD4和CD8蛋白的变化。
Am J Reprod Immunol. 1996 Oct;36(4):220-7. doi: 10.1111/j.1600-0897.1996.tb00167.x.
10
Increased soluble CD4 and decreased soluble CD8 molecules in patients with Sjögren's syndrome.
Am J Med. 1992 Feb;92(2):134-40. doi: 10.1016/0002-9343(92)90103-i.

引用本文的文献

1
Cytokines and soluble CD4 and CD8 molecules in rheumatoid arthritis: relationship to systematic vasculitis and microvascular capillaroscopic abnormalities.
Clin Rheumatol. 1998;17(6):489-95. doi: 10.1007/BF01451285.
2
Laboratory evaluation of the inflammatory myopathies.炎性肌病的实验室评估
Clin Diagn Lab Immunol. 1995 Jan;2(1):1-9. doi: 10.1128/cdli.2.1.1-9.1995.

本文引用的文献

1
Immunologic significance of increased soluble CD8/CD4 molecules in patients with active systemic lupus erythematosus.
J Clin Lab Anal. 1993;7(3):141-6. doi: 10.1002/jcla.1860070303.
2
Heterogeneity of precipitating antibodies in polymyositis and dermatomyositis. Characterization of the Jo-1 antibody system.多发性肌炎和皮肌炎中沉淀抗体的异质性。Jo-1抗体系统的特征。
Arthritis Rheum. 1980 Aug;23(8):881-8. doi: 10.1002/art.1780230802.
3
Detection of immune complexes in polymyositis.
Acta Neurol Scand. 1982 Apr;65(4):320-34. doi: 10.1111/j.1600-0404.1982.tb03089.x.
4
Peripheral blood Ia-positive T cells. Increases in certain diseases and after immunization.外周血Ia阳性T细胞。在某些疾病及免疫后数量增加。
J Exp Med. 1980 Jan 1;151(1):91-100. doi: 10.1084/jem.151.1.91.
5
Human cell surface glycoprotein related to cell proliferation is the receptor for transferrin.与细胞增殖相关的人细胞表面糖蛋白是转铁蛋白的受体。
Proc Natl Acad Sci U S A. 1981 May;78(5):3039-43. doi: 10.1073/pnas.78.5.3039.
6
A nuclear antigen associated with cell proliferation and blast transformation.一种与细胞增殖和原始细胞转化相关的核抗原。
J Exp Med. 1981 Dec 1;154(6):1899-909. doi: 10.1084/jem.154.6.1899.
7
Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro.可溶性白细胞介素2受体在体外从活化的人淋巴细胞中释放出来。
J Immunol. 1985 Nov;135(5):3172-7.
8
Serum interleukin-2-receptor in rheumatoid arthritis: a prognostic indicator of disease activity?类风湿关节炎中的血清白细胞介素-2受体:疾病活动的预后指标?
J Autoimmun. 1988 Aug;1(4):353-61. doi: 10.1016/0896-8411(88)90005-4.
9
Serum levels of interleukin-2 receptor and activity of rheumatic diseases characterized by immune system activation.以免疫系统激活为特征的风湿性疾病的血清白细胞介素-2受体水平及活性
Arthritis Rheum. 1988 Nov;31(11):1358-64. doi: 10.1002/art.1780311103.
10
Elevated soluble interleukin-2 receptor levels in the sera and synovial fluids of patients with rheumatoid arthritis.类风湿关节炎患者血清和滑液中可溶性白细胞介素-2受体水平升高。
Arthritis Rheum. 1988 Jul;31(7):844-9. doi: 10.1002/art.1780310704.